SCHEMBL9258076

SCHEMBL9258076

COc1cc(NS(=O)(=O)c2ccc(F)c(F)c2)ccc1-n1cnc(C)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 10/20 0.75
PSEN2 P49810 10/20 0.75
APH1B Q8WW43 10/20 0.75
NCSTN Q92542 10/20 0.75
APH1A Q96BI3 10/20 0.75
PSENEN Q9NZ42 10/20 0.75
SCN9A Q15858 1/20 0.53
LMNA P02545 5/20 0.53
ALDH1A1 P00352 4/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
HTT P42858 2/20 0.53
MAPT P10636 1/20 0.53
THRB P10828 1/20 0.53
PKM P14618 2/20 0.49
KDM1A O60341 1/20 0.48
TSHR P16473 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
KIT P10721 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9264936 0.89 PSEN1 (0.79) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8817931 0.88 PSEN1 (0.84) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9260877 0.87 PSEN1 (0.87) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9261724 0.87 PSEN1 (0.71) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9257166 0.86 PSEN1 (0.75) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9262799 0.86 PSEN1 (1.00) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9264550 0.85 PSEN1 (0.74) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8815854 0.85 PSEN1 (1.00) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8815757 0.85 PSEN1 (0.83) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8817444 0.85 PSEN1 (0.71) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND SHIONOGI & CO., LTD. (JP) 2012-05-31 US disclosed
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND SHIONOGI & CO., LTD. (JP) 2012-05-31 US disclosed
WO-2011007819-A1 PHARMACEUTICAL PRODUCT CONTAINING LACTAM OR BENZENE SULFONAMIDE COMPOUND 塩野義製薬株式会社 (JP) 2011-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND BACE1, STS, APP PSEN1 9/4885PSEN2 20/4885APH1B 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.